Longitudinal Analysis of Respiratory Syncytial Virus in Children during and after COVID-19 Pandemic in China: Shifts in Seasonality and Disease Burden
摘要
Non-pharmaceutical interventions (NPIs) against COVID-19 globally altered RSV seasonality, yet longitudinal evidence on age-specific severity changes remains scarce in China.
MethodsIn this hospital-based surveillance study, 20,305 children hospitalized with acute lower respiratory infection (ALRI) were enrolled. RSV was detected via RT-PCR across three phases: pre-pandemic (2017–2019), NPIs implementation (2020–2022), and post-NPIs (2023–2024).
ResultsRSV positivity varied significantly between phases (p < 0.001), peaking at 38.85% (742/1,910) in 2021. Seasonal peaks shifted from winter (pre-pandemic) to spring (post-NPIs). The disease burden shifted toward infants aged 7–12 months (38.92%, 845/2,171 vs. 20.55%, 200/973 pre-pandemic; p < 0.001). Notably, mechanical ventilation was required in 8.00% (4/50) and 5.71% (2/35) of severe pneumonia cases aged 13–36 months during Phases II and III, respectively, whereas no cases were recorded pre-pandemic (0/14; p > 0.05).
ConclusionNPIs fundamentally reshaped RSV epidemiology, inducing seasonal shifts and redirecting disease burden toward older infants experiencing delayed primary infection due to “immune debt.”